Therefore, although CAD mutations were present in only a very small percentage of all patients and were difficult to detect through unbiased, universal, and large-scale Sanger sequencing, they may dominantly determine the chemosensitivity of tumor tissue. This evidence concerns the gene CAD and neoplasm.